COMP <GO>
ARMP vs CHRS // NET PROFIT MARGIN
Armata Pharmaceuticals Inc. (NYSE) VS. Coherus Oncology Inc. (NASDAQ) • 15-METRIC TALLY: ARMP 1
— CHRS 2
■ METRIC PARITY
LAST: $2.85 (-13.11%) • MKT CAP: $122.0M
net-margins
—
LAST: $0.75 (-9.72%) • MKT CAP: $128.3M
net-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARMP VS. CHRS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARMP | CHRS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -21.77% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | CHRS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.8 | 34.3 | +9.50 | ARMP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $122.0M | $128.3M | -$6.3M | CHRS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARMP REV | CHRS REV | ARMP GROSS % | CHRS GROSS % | ARMP FCF | CHRS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $102.6M | $507.2M | — | — | -$26.3M | -$138.5M |
| FY 2024 | $118.8M | $559.0M | — | — | -$39.4M | -$20.4M |
| FY 2023 | $114.5M | $604.2M | — | — | -$47.4M | -$174.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARMP // BETA —
CHRS // BETA —